p38α-IN-12
p38α-IN-12 is an orally bioavailable p38α MAPK inhibitor, with an IC50 of 0.11 nM and a Ki of 0.2 nM against human targets. p38α-IN-12 inhibits the production of TNFα in cellular systems and exerts in vivo efficacy in acute mouse models.
For research use only. We do not sell to patients.
- CAS No.: 630106-85-3
- Formula: C22H17N7O2
- Molecular Weight:411.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PBMC | IC50 |
6 nM
Compound: 2x
|
Inhibition of LPS-induced TNFalpha production in human PBMC
Inhibition of LPS-induced TNFalpha production in human PBMC
|
[PMID: 18359226] |
p38α-IN-12 (compound 2x) inhibits LPS-induced TNFα production in human peripheral blood mononuclear cells with an IC50 of 6 nM[1].
p38α-IN-12 does not significantly inhibit human CYP 450 isoforms 1A2, 2C9, 2C19, 2D6, or 3A4, with IC50 values >40 μM for each[1].
p38α-IN-12 shows excellent metabolic stability in human and rat liver microsomes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | Bioavailability | Clearance (CL) | Vd | T1/2 |
|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | p.o. | 60 % | 0.3 | 1.3 L/kg | 4.1 h |
Chemical Information
-
CAS No. 630106-85-3
-
Molecular Weight 411.43
-
Formula C22H17N7O2
-
SMILES
O=C(NC1=NOC=C1)C2=CC=C(C(=C2)NC3=NC=NC4=C3C=NN4C=5C=CC=CC5)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)